Praxis Precision Medicines (PRAX) Tops Q3 EPS by 11c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q3 EPS of ($3.36), $0.11 better than the analyst estimate of ($3.47).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• UBS Starts Jiangsu Etern (600105:CH) at Buy
• Liberty Media Corp-Liberty Formula One (FWONA) PT Raised to $120 at Citizens
• Goldman Sachs Downgrades SkyWest (SKYW) to Neutral